NanoString Technologies, a provider of life science tools for translational research and molecular diagnostic products, has announced the availability of the nCounter Dx analysis system for high-complexity, CLIA-certified laboratories. ...
Tags: NanoString, DX Analysis System
US-based in vitro diagnostic company Venaxis announced that the Data and Safety Monitoring Board (DSMD) has recommended the continuation of pivotal clinical trial of the APPY1 test, a multiple biomarker-based assay for identifying patients ...
Tags: Appy1 Test, Clinical Trial
NanoString Technologies, a provider of life science tools for translational research and molecular diagnostic products, has obtained the US Food and Drug Administration (FDA) 510(k) clearance for its Prosigna breast cancer prognostic gene ...
Techne has completed the acquisition of Bionostics Holdings and its operating subsidiary Bionostics for approximately $104m in cash. Bionostics is a developer and manufacturer of control solutions that verify the correct operation of ...
Tags: Techne, Bionostics Acquisition
China-based Mindray Medical International has completed the acquisition of US-based ultrasound technology provider Zonare Medical Systems. Mindray entered into a definitive agreement on 12 June 2013 to acquire the US firm for $101.7m in ...
BD Diagnostics and Diagenode have jointly announced the Europe-only launch of a new real-time Diagenode Bordetella pertussis/parapertussis real-time polymerase chain reaction (PCR) kit for use on the BD MAX System. Timely detection of ...
Tags: BD Diagnostics, PCR Kit
US-based Techne has agreed to buy Bionostics Holdings and its operating subsidiary Bionostics, for $104m in cash. The deal is likely to close in the first quarter of fiscal 2014 Bionostics manufactures control solutions that authenticate ...
Tags: Bionostics, Techne
Advanced Biological Laboratories (ABL) has received CE Mark approval to market its patient monitoring application TherapyEdge in Europe. TherapyEdge helps to not only capture but also to integrate all patient data and particular decision ...
Tags: CE Mark, Monitoring Application
Analytical technologies provider AB SCIEX has launched the 3200MD CE-IVDD series for general in vitro diagnostic use in Europe. The new AB SCIEX API 3200MD and 3200MD QTRAP LC/MS/MS systems will help European hospitals and clinical ...
Tags: AB SCIEX, Diagnostic Devices
Spanish firm STAT-Diagnostica said it will invest $17m, arranged through Series B financing round, for completing the development of its Near Patient Testing diagnostic system. Using the proceeds, the company also plans to clinically ...
Theradiag has received a CE mark approval for its anti cyclic citrullinated peptide (anti-CCP) in vitro diagnostic (IVD) kit in rheumatoid arthritis. The test further expands the Fidis portfolio of diagnostic tests for auto-immunes ...
International Technidyne (ITC) has announced the European launch of an in vitro diagnostic (IVD) device for the quantitative measurement of prothrombin time international normalized ratio (PT/INR). Using a proprietary multi-channel ...
The US Patent and Trademark Office (USPTO) has granted a patent to Nanomix's patent application relating to flexible nanostructure electronic devices, such as nanotube sensors and transistors, and method for fabricating. The patent allows ...
Tags: diagnostics, Nanomix, Carbon Nanotube Sensor
Pathwork Diagnostics, a US-based developer of genomics-based diagnostics in oncology, has entered into a collaboration agreement with Kindstar Global to provide its FDA cleared in vitro diagnostic (IVD) kit version of the Pathwork Tissue of ...
Tags: cancer diagnosis test, Pathwork Diagnostics, cancer diagnosis
Molecular diagnostic cancer assays developer Predictive Biosciences has named Pierre Cassigneul as the company's new chief executive officer (CEO). Prior to joining the company, Cassigneul served as board vice chairman and president and ...
Tags: Predictive Biosciences, Pierre Cassigneul, CEO, diagnostic cancer assays